MedPath

山西国润制药有限公司

Ownership
-
Established
2003-03-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

150

NMPA:150

Drug Approvals

Acetylcysteine Injection

Product Name
乙酰半胱氨酸注射液
Approval Number
国药准字H20183359
Approval Date
Jul 26, 2023
NMPA

Acetylcysteine Solution for Inhalation

Product Name
吸入用乙酰半胱氨酸溶液
Approval Number
国药准字H20183229
Approval Date
Jun 26, 2023
NMPA

Oral Rehydration Salts Powder(Ⅲ)

Product Name
口服补液盐散(Ⅲ)
Approval Number
国药准字H20183200
Approval Date
Jun 16, 2023
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20183137
Approval Date
May 22, 2023
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20183135
Approval Date
May 22, 2023
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H14022649
Approval Date
Jun 3, 2021
NMPA

Hydrocortisone Injection

Product Name
氢化可的松注射液
Approval Number
国药准字H14020642
Approval Date
Jun 3, 2021
NMPA

Vitamin B1 Injection

Product Name
维生素B1注射液
Approval Number
国药准字H14020192
Approval Date
Jun 3, 2021
NMPA

Lincomycin Hydrochloride Injection

Product Name
盐酸林可霉素注射液
Approval Number
国药准字H14020646
Approval Date
Jun 3, 2021
NMPA

Kanamycin Sulfate Injection

Product Name
硫酸卡那霉素注射液
Approval Number
国药准字H14020670
Approval Date
Jun 3, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.